Protocol for Seahorse 3D Mito Stress assay in patient-derived atypical teratoid rhabdoid tumor CHLA-05-ATRT single neurospheres.
Overview
- Children’s Hospital Los Angeles, Cancer and Blood Disease Institute, Los Angeles, CA, USA
- Children’s Hospital Los Angeles, Saban Research Institute, Los Angeles, CA, USA
- Keck School of Medicine of University of Southern California, Department of Pediatrics, Los Angeles, CA, USA
- USC Norris Comprehensive Cancer Center, Epigenetic Regulation in Cancer Program, Los Angeles, CA, USA
Abstract
The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.
Code
The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.
The paper's code and data availability statement is in the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.
Data
No dataset and no data link were found in the paper.
Code and data availability statement
The paper has a code and data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:
- it says that the data are available on request
- it says that the code is available on request
Read it in the paper: doi.org/10.1016/j.xpro.2026.104515.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 30 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 2 authors, 3 keywords, 8 MeSH terms, 38 funders, 13 references.
Cite
This paper
Tocci, S., & Tsai, J. W. (2026). Protocol for Seahorse 3D Mito Stress assay in patient-derived atypical teratoid rhabdoid tumor CHLA-05-ATRT single neurospheres. STAR protocols, 7(2), 104515. https://
BibTeX
@article{tocci2026protoc
author = {Tocci, Stefania and Tsai, Jessica W.},
title = {{Protocol for Seahorse 3D Mito Stress assay in patient-derived atypical teratoid rhabdoid tumor CHLA-05-ATRT single neurospheres}},
journal = {STAR protocols},
year = {2026},
month = apr,
volume = {7},
number = {2},
pages = {104515},
publisher = {Elsevier},
issn = {2666-1667},
doi = {10.1016/
url = {https://
pmid = {42033730},
pmcid = {PMC13127629}
}
RIS
TY - JOUR
AU - Tocci, Stefania
AU - Tsai, Jessica W.
TI - Protocol for Seahorse 3D Mito Stress assay in patient-derived atypical teratoid rhabdoid tumor CHLA-05-ATRT single neurospheres
T2 - STAR protocols
J2 - STAR Protoc
PY - 2026
DA - 2026/
VL - 7
IS - 2
SP - 104515
SN - 2666-1667
PB - Elsevier
DO - 10.1016/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1016/
"type": "article-journal",
"title": "Protocol for Seahorse 3D Mito Stress assay in patient-derived atypical teratoid rhabdoid tumor CHLA-05-ATRT single neurospheres",
"container-title": "STAR protocols",
"author": [
{
"family": "Tocci",
"given": "Stefania"
},
{
"family": "Tsai",
"given": "Jessica W."
}
],
"container-title-short":
"volume": "7",
"issue": "2",
"page": "104515",
"DOI": "10.1016/
"PMID": "42033730",
"PMCID": "PMC13127629",
"ISSN": "2666-1667",
"publisher": "Elsevier",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
24
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1093/noajnl/vdag209
- Nuclear export inhibition activates TP53 pathways and is a potent therapeutic strategy in atypical teratoid rhabdoid tumors.Journal: Neuro-oncology advancesIn common: other condition, author Jessica W. Tsai
- [2] doi:10.1158/0008-5472.can-24-2248 [code]
- FOXR2 Targets LHX6+/
DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma. Journal: Cancer researchIn common: other condition, author Jessica W. Tsai - [3] doi:10.7554/elife.90993
- Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor.Journal: eLifeIn common: other condition, 3 references
- [4] doi:10.1186/s12916-024-03775-4
- Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma.Journal: BMC medicineIn common: other condition, 2 references
- [5] doi:10.1073/pnas.2115328119 [code]
- Noninvasive detection of any-stage cancer using free glycosaminoglycans.Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: other condition, 2 references
- [6] doi:10.1186/s12885-024-13187-5
- Human stem cell models to unravel brain cancer.Journal: BMC cancerIn common: other condition, 2 references
- [7] doi:10.3389/fphar.2022.1072253
- Serine and glycine metabolism-related gene expression signature stratifies immune profiles of brain gliomas, and predicts prognosis and responses to immunotherapy.Journal: Frontiers in pharmacologyIn common: other condition, 2 references
- [8] doi:10.3389/fimmu.2024.1431112
- Metabolic adaptation of myeloid cells in the glioblastoma microenvironment.Journal: Frontiers in immunologyIn common: other condition, 2 references
- [9] doi:10.1038/s41467-024-54352-5 [code]
- Proteomic profiling of gliomas unveils immune and metabolism-driven subtypes with implications for anti-nucleotide metabolism therapy.Journal: Nature communicationsIn common: other condition, 2 references
- [10] doi:10.1038/s41419-022-05005-2
- Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation.Journal: Cell death & diseaseIn common: other condition, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
